Product NDC: | 25021-778 |
Proprietary Name: | granisetron hydrochloride |
Non Proprietary Name: | granisetron hydrochloride |
Active Ingredient(s): | .1 mg/mL & nbsp; granisetron hydrochloride |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-778 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091136 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101201 |
Package NDC: | 25021-778-01 |
Package Description: | 5 VIAL in 1 CARTON (25021-778-01) > 1 mL in 1 VIAL |
NDC Code | 25021-778-01 |
Proprietary Name | granisetron hydrochloride |
Package Description | 5 VIAL in 1 CARTON (25021-778-01) > 1 mL in 1 VIAL |
Product NDC | 25021-778 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | granisetron hydrochloride |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20101201 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | GRANISETRON HYDROCHLORIDE |
Strength Number | .1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |